Researchers have created a prototype system that uses a mathematical model to predict – and a portable inkjet technology to produce – precise medication dosages tailored for specific patients, an advance in personalized medicine that could improve drug effectiveness and reduce adverse reactions.
Drug makers now manufacture tablets based on clinical studies that determine the average recommended dose. Often this average falls outside of the optimal dose for a particular patient, but there is no way to precisely adjust the dosage except by trial and error.
“Pharmaceutical companies make one or two or three dosage levels, so people try breaking tablets in half and other methods to get to the right dosage,” said Gintaras “Rex” Reklaitis, Purdue University’s Burton and Kathryn Gedge Distinguished Professor of Chemical Engineering.
Delivering a more precise dosage improves the effectiveness of drugs and reduces potential side effects.
“Many drugs have a minimum effective level, so you need to meet that, and many of them have a toxic level,” he said. “The closer you get to it the more side effects there are.”
The new approach uses a combination of data and mathematics to determine the precise dosage. Two or three blood samples are drawn from the patient after a small quantity of the drug is administered. Data from those samples are combined with information from clinical studies of larger numbers of patients, and mathematical models are used to determine the proper dose for a particular patient.
Then, a portable technology dissolves or melts the drugs with polymers and uses “drop-on-demand” inkjet printing technology to deposit exact quantities onto tablets or films. Melting medications requires more careful control than simply dissolving them. However, melting could offer benefits over solutions, Reklaitis said. Many of the newest drugs are poorly soluble in the bloodstream. Precisely controlling temperatures during the melting procedure could allow drug makers to control the drug properties and increase solubility.
“We envision that in its final form the printing will be done in an automated fashion. The pharmacist could key in the dose, the machine prints 20 tablets, and off you go,” said Reklaitis, who is working with a team of researchers led by Arun Giridhar, an associate research scientist in the School of Chemical Engineering, and Poching DeLaurentis, a research scientist in Purdue’s Oncological Sciences Center.
The team has built a prototype and is working toward commercialization of a device, which is about the size of a large laser printer. Recent research findings are detailed in papers published this year in the Journal of Pharmaceutical Sciences and the journal Pharmacotherapy.
The dosage-prediction research was pioneered by Gary E. Blau, a visiting professor in the School of Chemical Engineering, who died earlier this year. It has been funded by the National Science Foundation.
One of the research papers focuses on the mathematical method for predicting a patient’s dose while the other describes the drop-on-demand technology applied to solvent-based systems, work that has been supported under the NSF Engineering Research Centers (ERC) program.
“If we say the patient needs 23 milligrams every eight hours, there is no 23-milligram tablet on the market,” Giridhar said. “I can make a 23-milligram dose, but to make something that small and that precise is challenging to do with powders. It is much easier to dissolve or melt the drug formulation. Both are viable technologies.”
In personalized medicine, physicians use diagnostic methods to determine the precise therapy for each patient.
“We are saying that’s great, but you are still faced with the problem of how to administer the drug,” said Reklaitis, deputy director of an NSF ERC formed in 2006 to improve the way pharmaceuticals, foods and agricultural products are developed and manufactured.
“In the past, we haven’t had the mathematical tools to do this.”
DeLaurentis focuses on the mathematical and statistical methods required to determine the drug dosage, building on research initiated by Blau, Reklaitis and former postdoctoral research associate Jose M. Lainez. Giridhar is leading research to develop the portable system with doctoral student Elcin Icten. The work on the printing device also is supported by the Indiana Next Generation Manufacturing Competitiveness Center – IN-MaC – led by Purdue to attract, retain and grow high-value manufacturing industries in the state.
Researchers are involved in clinical studies to learn how effective the procedure is.
The same strategy – using prediction methods coupled with limited blood sampling – could enable health care professionals to monitor a drug’s effectiveness over time and adjust the dosage for the patient as needed.
The Latest on: Precise drug dosages
via Google News
The Latest on: Precise drug dosages
- Oral Dosing Pipettes Market Global Outlook on Key Growth Trends, Factorson January 24, 2020 at 3:24 am
Oral dosing pipettes offer high-precise dosing for relatively large dosing volumes. Oral dosing pipettes are also used to deliver the drug to unconscious patient and infants. The technological changes ...
- Single Use Tube Market 2020 Revenue by Global Industry Players and Forecast to 2028on January 24, 2020 at 3:21 am
However, Single use tube manufactured according to the drug effect in precise dosage. It helps to reduce the contamination risks, labor expense, and time, and also saves energy and cost by eliminating ...
- Duncanson acquitted of all counts in St. Mary's murder trialon January 21, 2020 at 9:25 pm
A representative from the Office of the Chief Medical Examiner testified the precise time of Ellis’ death ... “through the grapevine” two names of drug dealers who had allegedly given the lethal dose ...
- Milestone Scientific Receives Notice of Allowance for U.S Patent Related to Cosmetic Injection Systemon January 21, 2020 at 2:59 am
LIVINGSTON, NJ / ACCESSWIRE / January 21, 2020 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...
- Global Healthcare Contract Manufacturing Market 2020 Precise Outlook – (AbbVie, Boehringer Ingelheim, Grifols International, S.…More)on January 21, 2020 at 1:59 am
Healthcare Contract Manufacturing Market 2020 Global Industry research report gives a comprehensive analysis of the Healthcare Contract Manufacturing industry size, growth factors, demand, global ...
- Precise safety pharmacology studies of lapatinib for onco-cardiology assessed using in vivo canine modelson January 20, 2020 at 2:06 am
Lapatinib significantly increased the cTnI at 60 min after the high dose, whereas no significant increase was detected in the other markers. The time courses of the changes in the electrocardiogram ...
- Jury acquits Duncanson of all counts in St. Mary's murder trialon January 17, 2020 at 4:07 pm
A representative from the Office of the Chief Medical Examiner testified the precise time of Ellis' death ... had heard "through the grapevine" two names of drug dealers who had allegedly given the ...
- Gofire Launches Patented, Metered-dose Inhaler to Vaporization Market Seeking Safe, Accurate Dose Controlon November 14, 2019 at 6:03 am
Together, the Gofire Inhaler and Gofire App create a “smart health ecosystem” enabling the precise dosage and replicable experience patients and physicians have been seeking from alternative ...
- Impact Story: Finding a Better Test for Predicting the Risk Drugs Pose to the Hearton October 28, 2019 at 7:15 am
This additional trial, called the TQT study, was added to determine whether the drug could cause a fatal heart arrhythmia. In a TQT study, healthy study participants are given a high dose of a ...
- Rapid Dose Therapeutics Completes Quickstrip™ Equipment Installation at Aphria Inc.on September 9, 2019 at 5:00 pm
we believe the QuickStrip™ will help ease concerns surrounding consumption by providing a smoke-free product that delivers a consistent and precise dosage,” added Simon. About Rapid Dose ...
via Bing News